← SynDRA
BALIPODECT
SynDRA canonical compound SYN0039191 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | PDE10A |
|---|
| Mechanism of action | phosphodiesterase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- PDE10A INHIBITOR
- Phosphodiesterase 10A inhibitor
- phosphodiesterase inhibitor
Cross-references
Synonyms
- TAK-063
- TAK 063
- balipodectum
- RefChem:916695
- Balipodect [INN]
- Balipodect [USAN]
- Balipodect [WHO-DD]
- C23H17FN6O2
- 3wym
- MFCD28385852
- Balipodect (USAN/INN)
- SCHEMBL518714
- orb1307553
- SCHEMBL30123098
- EX-A568
- Balipodect [USAN:INN:WHO-DD]
- KVHRYLNQDWXAGI-UHFFFAOYSA-N
- GLXC-07545
- HMS3886P10
- UNII-6650W303H0
- TAK-063?
- s8459
- AKOS026750192
- CCG-268978
- CS-3551
- SB17000
- NCGC00390654-01
- AC-32915
- BS-15045
- DA-46880
- HY-12472
- D11245
- BRD-K57155378-001-01-1
- 3K9
- 1-[2-fluoro-4-(1H-pyrazol-1-yl)phenyl]-5-methoxy-3-(1-phenyl-1H-pyrazol-5-yl)pyridazin-4(1H)-one
Look up BALIPODECT in the interactive SynDRA portal →